2051 Ringwood Avenue
29 articles with Rani Therapeutics
1/14/2022Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Rani Therapeutics Holdings, Inc. today announced the appointment of Lisa Rometty to its Board of Directors.
11/19/2021Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today reported financial results for the quarter ended September 30, 2021, and provided a corporate update.
Rani Therapeutics Holdings, Inc., a clinical stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics, announced the appointment of Lyn Baranowski to its Board of Directors.
Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthcare Conference
Rani Therapeutics (NASDAQ: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today announced that the company’s Chief Executive Officer, Talat Imran, will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on Wednesday, November 17, 2021, at 7:00 a.m. PT / 10:00 a.m. ET.
Rani Therapeutics (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today announced that the company’s Chief Executive Officer, Talat Imran, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 30, 2021, at 9:00 a.m. PT / 12:00 p.m. ET.
Rani Therapeutics Holdings, Inc. today announced the appointment of Eric Groen as General Counsel.
7/14/2021More biopharma companies race toward the Nasdaq this week, while a few rake in cash via private funding rounds.
The 2021 IPO stampede continues with five more companies aiming to trade on a stock exchange.
BioSpace recently spoke with Mir Imran, CEO and Chief Innovator at Rani Therapeutics, a company developing and testing a “robotic” pill that delivers biologics orally.
Study Met All Primary and Secondary Endpoints
Rani Therapeutics, creator of the robotic RaniPill™ capsule designed to replace injections of large drug molecules including peptides, proteins, and antibodies, today announced that Svai Sanford has joined the company as its first Chief Financial Officer.
Most people would prefer to take a pill over an injection, and even an injection over an infusion. But not all drugs can be taken orally. In particular, this applies to most biologics, including insulin.
First Human Study of "Robotic" RaniPill™ Capsule to Replace Injections Announced by Rani Therapeutics
Safety and Tolerability of RaniPill™ Capsule in Humans Advances Oral Delivery of Injectable Biologic Drugs
Annual program honors investors, creatives, backers and masters who represent the most dynamic, disruptive and innovative people doing business in the San Francisco Bay Area
Prolific inventor, serial entrepreneur and creator of the RaniPill™ capsule recognized for unbridled curiosity and passion for solving difficult problems
He previously served as Chief of Medicine at Massachusetts General Hospital from 1996 until 2013.
Rani Therapeutics, a pioneer in oral biologics, today announced that Rodolphe Ruffy, M.D. has joined the company as medical director.
Oral Biologics Delivery Could Be The Key For Biosimilars To Gain Market Share From Blockbuster Drugs
Doctors believe moving Rheumatoid Arthritis and Crohn's Disease patients from AbbVie's injectable Humira® (adalimumab) to an oral adalimumab would improve patient compliance